HSPA5 Could Be a Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer

Abstract

Background. Breast cancer (BC) is a frequent disease in females. The heat shock 70 kDa protein 5 (HSPA5) has recently been discovered to have an important function in tumor growth. However, the biological significance of HSPA5 in BC is unknown. Material and Method. Firstly, The Cancer Genome Atlas (TCGA) database was applied to analyze the expressions of HSPA5 in different cancer types, especially in BC. Then, the LinkedOmics database was used to screen genes coexpressed with HSPA5 in BC, presented by protein-protein interaction (PPI) and analyzed by functional enrichment analyses. Next, the Kaplan-Meier plotter was adopted to study the prognostic significance of HSPA5 and the relation between HSPA5 expression and different clinical factors in BC. Finally, the Tumor Immune Estimation Resource (TIMER) method was adopted to explore the relation between immune infiltration and HSPA5 in BC. Result. HSPA5 was highly expressed in most cancers, including BC. Genes coexpressed with HSPA5 were mainly related to endoplasmic reticulum unfolded protein response, melanosome, thyroid hormone synthesis, N-glycan biosynthesis, and so on. In the survival analysis, high HSPA5 expression indicated a poor prognosis in BC, and the expression of HSPA5 in BC was elevated after the incidence of BC, changing with different clinical factors. In the immune infiltration, HSPA5 was positively correlated with most immune cells. Conclusion. HSPA5 is an oncogene in BC progression, and it is connected with the prognosis and the immune infiltration in BC. Our findings suggest that HSPA5 could be an immunotherapy target and a prognostic biomarker in BC.

Identification and validation of a glycolysis-related gene signature for predicting metastasis and survival rate in patients with thyroid cancer

“…Leave-one-out cross validation and ROC analysis indicated that the gene feature had a moderate effect on predicting survival rate. Previous studies suggested that the three GRGs we found were all related to the occurrence and development of some cancers ( 29 - 31 ). For example, decreased expression of HSPA5 is associated with the deterioration of clinical pathological characteristics, shortened PFI, and increased immune infiltration of various immune cells, indicating that HSPA5 is a biomarker for the prognosis of THCA ( 32 ).…”

Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in cervical carcinoma

“…High expression of HSPA5 was found in lung cancer, gastric cancer, prostate cancer, CC and other tumor cells. As a cancer promoting factor, HSPA5 can reduce the lethal effect of cytotoxic T cells on tumor cells, protect tumor cells from the control of the body's immunity, and thus promote the occurrence and development of tumors [33] . This is also the case in our study, where high expression of HSPA5 in CC is associated with lower survival and poor prognosis.…”

New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19

“…By analyzing the database of The Cancer Genome Atlas (TCGA), the Tumor Immune Estimation Resource (TIMER) method, the Kaplan-Meier plotter, or Cox regression, Zhang et al. ( 17 ) concluded that HSPA5 is a marker for prognostics that correlates with immune infiltration of breast cancer. Dong et al.…”